✦ LIBER ✦

Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring

✍ Scribed by Christine Hsieh; Anthony Chang; Daniel Brandt; Riteesha Guttikonda; Tammy O. Utset; Marcus R. Clark

Book ID: 101401740
Publisher: Wiley (John Wiley & Sons)
Year: 2011
Tongue: English
Weight: 197 KB
Volume: 63
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.20441

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical outcome and occurrence of uveit

Clinical outcome and occurrence of uveitis in children with idiopathic tubulointerstitial nephritis

✍ Timo Jahnukainen; Marja Ala-Houhala; Riitta Karikoski; Janne Kataja; Ville Saare 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 143 KB

Predicting renal outcomes in severe lupu

Predicting renal outcomes in severe lupus nephritis: Contributions of clinical and histologic data

✍ Austin, Howard A; Boumpas, Dimitrios T; Vaughan, Ellen M; Balow, James E 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 722 KB

A Systematic Review and Meta-Analysis of

A Systematic Review and Meta-Analysis of Pregnancy Outcomes in Patients with Systemic Lupus Erythematosus and Lupus Nephritis

✍ Smyth, A.; Oliveira, G. H. M.; Lahr, B. D.; Bailey, K. R.; Norby, S. M.; Garovic 📂 Article 📅 2010 🏛 American Society of Nephrology 🌐 English ⚖ 116 KB

Pregnancy in women with pre-existing lup

Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome

✍ Imbasciati, E.; Tincani, A.; Gregorini, G.; Doria, A.; Moroni, G.; Cabiddu, G.; 📂 Article 📅 2008 🏛 Oxford University Press 🌐 English ⚖ 98 KB

Histopathologic and clinical outcome of

Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis

✍ Iva Gunnarsson; Birgitta Sundelin; Thorunn Jónsdóttir; Stefan H. Jacobson; Elisa 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract ## Objective Rituximab is a monoclonal antibody directed against the CD20 marker of B cells. Because of its ability to deplete B lymphocytes, it has been suggested that the drug could be of benefit in B cell–dependent diseases, including systemic lupus erythematosus (SLE). The purpose

Long-term mortality and renal outcome in

Long-term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis

✍ Mikkel Faurschou; Lene Dreyer; Anne-Lise Kamper; Henrik Starklint; Søren Jacobse 📂 Article 📅 2010 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 103 KB 👁 2 views